Tamoxifen and Endometrial Cancer

This publication has 40 references indexed in Scilit:

• A Risk-Benefit Assessment of Tamoxifen Therapy
  Drug Safety, 1993
• Endometrial lesions in patients undergoing tamoxifen therapy
  International Journal of Gynecology & Obstetrics, 1991
• The role of vaginal scan in measurement of endometrial thickness in postmenopausal women
  BJOG: An International Journal of Obstetrics and Gynaecology, 1991
• Tamoxifen for breast cancer: Associated endometrial cancer
  Cancer, 1990
• Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programme
  European Journal of Cancer and Clinical Oncology, 1990
• A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
  New England Journal of Medicine, 1989
• The Stockholm trial on adjuvant tamoxifen in early breast cancer
  Breast Cancer Research and Treatment, 1987
• Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: Problems and potential for future clinical applications
  Breast Cancer Research and Treatment, 1983
• Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata
  Published by Elsevier ,1976
• 243. Antitumour activity of the antiestrogen ICI 46,474 (Tamoxifen) in the dimethylbenzanthracene (DMBA)—induced rat mammary carcinoma model
  Journal of Steroid Biochemistry, 1974